All The Claims

1. An apparatus for optimizing performance of a multiple core processor, the apparatus comprising:
a testing device that identifies a voltage value for each component of a multiple core processor die, wherein the multiple core processor die comprises a plurality of components; and
a bond and assembly device that sets a switch in a package for each component of the multiple core processor die based on the identified voltage value for each component, wherein each switch connects a component of the multiple core processor die to one of a plurality of voltage planes formed in the package and wherein the number of voltage planes in the plurality of voltage planes is less than the number of components in the plurality of components, and bonds the multiple core processor die to the package.
2. The apparatus of claim 1, wherein the plurality of components comprises a plurality of processor cores.
3. The apparatus of claim 2, wherein the plurality of processor cores comprises a heterogeneous multiple core processor architecture.
4. The apparatus of claim 2, wherein the plurality of components further comprises a memory component, an inputoutput logic component, or a pervasive logic component.
5. The apparatus of claim 1, further comprising:
a database that stores the identified voltage values for the plurality of components in association with a chip identifier of the multiple core processor die.
6. The apparatus of claim 5, wherein the testing device stores the chip identifier on the multiple core processor die.
7. The apparatus of claim 1, wherein the testing device determines a voltage value for each of a plurality of voltage regulator modules, wherein each voltage regulator module in the plurality of voltage regulator modules is configured to supply a voltage to one of the plurality of voltage planes in the package.
8. The apparatus of claim 7, wherein the testing device stores the voltage value for each of the plurality of voltage regulator modules as a voltage identifier on the multiple core processor die.
9. A package for optimizing performance of a multiple core processor, the package comprising:
a plurality of voltage planes; and
a plurality of switches, wherein each switch is configured to be set for each component of a multiple core processor die, wherein the multiple core processor die comprises a plurality of components, wherein each switch is configured to connect a component of the multiple core processor die to one of the plurality of voltage planes, and wherein the number of voltage planes in the plurality of voltage planes is less than the number of components in the plurality of components.
10. The package of claim 9, wherein the package is bonded to the multiple core processor die.
11. The package of claim 9, further comprising:
wherein each voltage plane of the plurality of voltage planes is coupled to a corresponding one of a plurality of voltage regulator modules, and wherein a number of voltage regulator modules in the plurality of voltage regulator modules is equal to the number of voltage planes in the plurality of voltage planes.
12. The package of claim 11, further comprising:
wherein each of a plurality of voltage identifiers stored on the multiple core processor die is coupled to a corresponding voltage regulator module in the plurality of voltage regulator modules.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. Connection module for telecommunication and data technique, entailing a base plate, onto which connecting modules for optical waveguides or electrical cores can be arranged, with the connecting modules and the base plate manifesting fitting agents corresponding to one another, wherein at least one connecting module for optical waveguides and at least one connecting module for electrical cores have been arranged on a base plate.
2. Connection module according to claim 1, wherein the connecting modules are detachably connected with the base plate.
3. Connection module according to claim 1, wherein the base plate is equipped with connecting elements to form a carrier system.
4. Connection module according to claim 1, wherein the base plate is made of plastic.
5. Connection module according to claim 1, wherein the connecting module for the electrical cores is designed as a connection block.
6. Connection module according to claim 1, wherein the connecting module for the electrical cores possesses contacts for the connection of the cores, the contacts being insulation displacement contacts.
7. Connection module according to claim 1, wherein the connecting module for the optical waveguides is made of plastic.
8. Connection module according to claim 1, wherein the connecting module for the optical waveguides has been provided with fibre guidance structures.
9. Connection module according to claim 8, wherein the fibre guidance structures are transient bores.
10. Connection module according to claim 8, wherein the connecting module is made in two parts, V-shaped grooves have been worked into the lower part and the top part has been designed in such a way that an inserted optical waveguide is pushed into the V-shaped groove when the bottom and the top part are pushed together.
11. Connection module according to claim 10, wherein at least one cutting device has been arranged in the top part, by means of which an optical waveguide can be cut off vertical to the axes.
12. Connection module according to claim 1, wherein a reservoir with an immersion fluid has been arranged in the connecting module for the optical waveguides.
13. Connection module according to claim 12, wherein the reservoir has been arranged in the top part.
14. Connecting module for optical waveguides, entailing a housing and fibre guidance structures, with at least two waveguides being able to be brought into contact in pairs in the housing, wherein the connecting module manifests fitting agents for a base plate.
15. Connecting module according to claim 14, wherein the housing is made of plastic.
16. Connecting module according to claim 14, wherein the fibre guidance structures are transient bores.
17. Connecting module according to claim 14, wherein the housing comprises at least two parts, with V-shaped grooves having been worked into a lower part and a top part being designed in such a way that an inserted optical waveguide is pushed into the V-shaped groove when the bottom and the top part are pushed together.
18. Connecting module according to claim 17, wherein at least one cutting device has been arranged in the top part, by means of which an optical waveguide can be cut off vertical to the axes.
19. Connecting module according to claim 14, wherein a reservoir with an immersion fluid has been arranged in the connecting module.
20. Connecting module according to claim 19, wherein the reservoir has been arranged in the top part.
21. Connecting module according to claim 14, wherein the connecting module has been provided with means for the centring of fibre end sleeves or ferrules.
22. Connecting module according to claim 14, wherein the optical waveguide is designed as an optical plastic fibre.
23. Connecting module according to claim 14, wherein the optical waveguide is designed as an HCS fibre or as a glass fibre.
24. Method for the connection of two optical waveguides, in particular of optical plastic fibres, by means of a connecting module according to claim 14, entailing the following procedural steps:
a) removal of the outer casing of the two optical waveguides;
b) cutting off the two fibre ends which are to be connected with one another vertical to the axes and
c) insertion of the two fibre ends from different sides of a fibre guidance element until they are opposite one another and in contact.
25. Method according to claim 24, wherein the joint position is filled with an immersion fluid.

1-17. (canceled)
18. A pharmaceutical composition comprising:
Lyxumia (lixisenatide), Lemtrada (alemtuzumab), REGN727SAR236553 (alirocumab), SAR2405550BSI-201 (iniparib), Otamixaban (otamixaban), Sarilumab (sarilumab), Lantus and Lyxumia (insulin glargine and lixisenatide) or VisamerinMulsevo (semuloparin sodium) and a pharmaceutically acceptable excipient;
wherein the pharmaceutical composition is contained within a glass pharmaceutical container comprising a glass composition comprising:
SiO2 in a an amount greater than or equal to about 72 mol. % and less than or equal to about 78 mol. %;
alkaline earth oxide comprising both MgO and CaO, wherein CaO is present in an amount up to about 1.0 mol. %, and a ratio (CaO (mol. %)(CaO (mol. %)+MgO (mol. %))) is less than or equal to 0.5;
X mol. % Al2O3, wherein X is greater than or equal to about 5 mol. % and less than or equal to about 7 mol. %;
Y mol. % alkali oxide, wherein the alkali oxide comprises Na2O in an amount greater than about 8 mol. %; and
a ratio of a concentration of B7O3 (mol. %) in the glass container to (Y mol. %\u2212X mol. %) is less than or equal to 0.3.
19. The pharmaceutical composition of claim 18, wherein the pharmaceutical container comprises a compressive stress greater than or equal to 150 MPa.
20. The pharmaceutical composition of claim 18, wherein the pharmaceutical container comprises a compressive stress greater than or equal to 250 MPa.
21. The pharmaceutical composition of claim 18, wherein the pharmaceutical container comprises a depth of layer greater than 30 \u03bcm.
22. (canceled)
23. The pharmaceutical composition of claim 18, wherein the pharmaceutical composition comprises increased stability, product integrity, or efficacy.
24. A pharmaceutical composition comprising:
Lyxumia (lixisenatide), Lemtrada (alemtuzumab), REGN727SAR236553 (alirocumab), SAR2405550BSI-201 (iniparib), Otamixaban (otamixaban), Sarilumab (sarilumab), Lantus and Lyxumia (insulin glargine and lixisenatide) or VisamerinMulsevo (semuloparin sodium) and a pharmaceutically acceptable excipient;
wherein the pharmaceutical composition is contained within a glass pharmaceutical container comprising an internal homogeneous layer and a compressive stress greater than or equal to 150 MPa.
25. The pharmaceutical composition of claim 24, wherein the pharmaceutical container comprises a depth of layer greater than 10 \u03bcm.
26. The pharmaceutical composition of claim 25, wherein the pharmaceutical container comprises a depth of layer greater than 25 \u03bcm.
27. The pharmaceutical composition of claim 24, wherein the pharmaceutical container has a delamination factor of less than 3.
28. (canceled)
29. The pharmaceutical composition of claim 24, wherein the pharmaceutical container comprises increased stability, product integrity, or efficacy.
30. A pharmaceutical composition comprising:
Lyxumia (lixisenatide), Lemtrada (alemtuzumab), REGN727SAR236553 (alirocumab), SAR2405550BSI-201 (iniparib), Otamixaban (otamixaban), Sarilumab (sarilumab), Lantus and Lyxumia (insulin glargine and lixisenatide) or VisamerinMulsevo (semuloparin sodium) and a pharmaceutically acceptable excipient;
wherein the pharmaceutical composition is contained within a glass pharmaceutical container having a compressive stress greater than or equal to 150 MPa and a depth of layer greater than 10 \u03bcm, and wherein the pharmaceutical composition comprises increased stability, product integrity, or efficacy.
31. (canceled)
32. A pharmaceutical composition comprising:
Lyxumia (lixisenatide), Lemtrada (alemtuzumab), REGN727SAR236553 (alirocumab), SAR2405550BSI-201 (iniparib), Otamixaban (otamixaban), Sarilumab (sarilumab), Lantus and Lyxumia (insulin glargine and lixisenatide) or VisamerinMulsevo (semuloparin sodium) and a pharmaceutically acceptable excipient;
wherein the pharmaceutical composition is contained within a glass pharmaceutical container comprising a delamination factor of less than 3, wherein the pharmaceutical composition comprises increased stability, product integrity, or efficacy.
33. A pharmaceutical composition comprising:
Lyxumia (lixisenatide), Lemtrada (alemtuzumab), REGN727SAR236553 (alirocumab), SAR2405550BSI-201 (iniparib), Otamixaban (otamixaban), Sarilumab (sarilumab), Lantus and Lyxumia (insulin glargine and lixisenatide) or VisamerinMulsevo (semuloparin sodium) and a pharmaceutically acceptable excipient;

wherein the pharmaceutical composition is contained within a glass pharmaceutical container which is substantially free of boron, and wherein the pharmaceutical composition comprises increased stability, product integrity, or efficacy.
34. The pharmaceutical composition of claim 33, wherein the glass pharmaceutical container comprises a compressive stress greater than or equal to 150 MPa and a depth of layer greater than 25 \u03bcm.
35. The pharmaceutical composition of claim 34, wherein the glass pharmaceutical container comprises a compressive stress greater than or equal to 300 MPa and a depth of layer greater than 35 \u03bcm.
36. The pharmaceutical composition of claim 33, wherein said glass pharmaceutical container comprises a substantially homogeneous inner layer.
37. The pharmaceutical composition of claim 36, wherein said glass pharmaceutical container comprises a compressive stress greater than or equal to 150 MPa and a depth of layer greater than 25 \u03bcm.
38-44. (canceled)
45. The pharmaceutical composition of claim 18, wherein the pharmaceutical container comprises an internal homogeneous layer.
46. The pharmaceutical composition of claim 27, wherein the pharmaceutical container comprises increased stability, product integrity, or efficacy.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A mounting assembly for a wheel suspension system of a vehicle having a vehicle body, said mounting assembly comprising:
a support structure having an aperture and adapted to be mounted to the vehicle body;
a piston rod at least partially disposed within said aperture and displaceable relative to said support structure along a line of travel;
a plate mounted to said piston rod and moving relative to said support structure during said displacement of said piston rod;
an insulator disposed about said piston rod between said support structure and said plate with said insulator abutting said plate for coupling said piston rod to said support structure;
said insulator having a first portion defining a first resistance and a first maximum width for isolating said displacement of said piston rod and said plate during an application of a first force along said line of travel in a first direction which at least partially compresses said first portion, and a second portion defining a second resistance and a second maximum width with said second resistance being greater than said first resistance for controlling said displacement of said piston rod and said plate after said application of said first force and during an application of a second force along said line of travel in said first direction wherein said second force is greater than said first force such that both said first and second portions are at least partially compressed and said second width being larger than said first width to define a ledge on said second portion extending outwardly beyond said width of said first portion; and
a jounce bumper disposed about said piston rod and mounted to said plate on an opposite side from said insulator for translating movement of the wheel suspension system during application of said second force;
said plate having a width at least equal to said maximum width of said second portion and a maximum width of said jounce bumper;
said support structure including a first cup defining a cavity and an inner surface with said first portion of said insulator at least partially disposed within said cavity and configured to be contiguous with said inner surface for compressing said first portion without compressing said ledge and said second portion when said first force is applied;
said support structure further including a flange extending outwardly from said first cup with said flange uniformly positioned relative to said ledge for positioning said ledge between said flange and said plate such that during said application of said second force, said ledge of said second portion engages and compresses against said flange to transmit loads of said second force from said plate to said support structure.
2. The assembly as set forth in claim 1 wherein said first portion is at least partially compressed before said second portion is at least partially compressed.
3. The assembly as set forth in claim 1 wherein said first and second portions of said insulator are formed of a common homogeneous material of micro-cellular polyurethane.
4. The assembly as set forth in claim 1 wherein said first portion has a first height and said second portion has a second height smaller than said first height.
5. The assembly as set forth in claim 1 wherein said piston rod includes a notch with said plate abutting said notch to mount said plate to said piston rod.
6. The assembly as set forth in claim 1 wherein said first and second portions of said insulator are formed of the same material.
7. The assembly as set forth in claim 4 wherein said first height is 3 times larger than said second height.
8. The assembly as set forth in claim 1 wherein said first portion has an annular configuration defining a first circumference.
9. The assembly as set forth in claim 8 wherein said second portion has an annular configuration defining a second circumference which is larger than said first circumference to define an annular ledge on said second portion extending outwardly beyond said circumference of said first portion.
10. The assembly as set forth in claim 9 wherein said first portion and said second portion having said annular ledge are formed of a common homogeneous material.
11. The assembly as set forth in claim 1 wherein said insulator is mounted to said piston rod.
12. The assembly as set forth in claim 1 further including a second insulator mounted to said support structure for further coupling said piston rod to said support structure and for further isolating said displacement of said piston rod and said plate when said first force is applied along said line of travel in said first direction.
13. The assembly as set forth in claim 12 wherein said support structure includes a second cup with said second insulator mounted within said second cup.